Trial intelligence / Profile preview

Phase II nab-paclitaxel + capecitabine in HER2-negative metastatic breast cancer (first-line)

2012-000393-35Phase 2Completed

Sponsor

GOIM

Start

Mar 2012

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1